-
1
المؤلفون: Marleen Bouhuys, Willem S. Lexmond, Patrick F. van Rheenen
المصدر: Biomedicines. 10(5)
مصطلحات موضوعية: ETANERCEPT 25 MG, tumor necrosis factor inhibitors, Medicine (miscellaneous), ANKYLOSING-SPONDYLITIS, TARGET RECOMMENDATIONS, FACTOR INHIBITORS, General Biochemistry, Genetics and Molecular Biology, LOW DISEASE-ACTIVITY, RHEUMATOID-ARTHRITIS, certolizumab pegol, ANTI-TNF AGENTS, CLINICAL REMISSION, dose reduction, interval lengthening, adalimumab, PSORIATIC-ARTHRITIS, adverse effects, golimumab, infliximab, etanercept